Spago Nanomedical Plans to Seek Delisting, Pending EGM Approval
Spago Nanomedical plans to apply for delisting from Nasdaq First North, subject to approval at a 19 November 2026 EGM. The last trading day is expected in February 2027; major holders owning about 65% have indicated support.
Story updates
05:35:38 PM UTC
SquawkNews
Spago Nanomedical AB (publ) called a Nov. 19, 2026 EGM to approve applying for delisting from Nasdaq First North Growth Market, requiring at least 9/10 support under Swedish Delisting Rules.Material DetailsContext by AI AnalystThis is a strategic pivot to exit public markets amid funding needs for…